Skip Navigation

Your Environment. Your Health.

Licensing Opportunities

The inventions created in NIEHS laboratories may be transferred to the private sector for further research and development, and eventual commercialization through licenses. A company may acquire any of the following licenses:


  • Unpatented Material
  • Patented Material
  • Patent-pending Material
  • Commercial Evaluation
  • Biological Materials
  • Exclusive/Nonexclusive


The licensing application and negotiation process for institutes within the National Institutes of Health (NIH) is managed by the NIH Office of Technology Transfer .


NIEHS Technologies Available for Licensing & Collaborative Development

AntibodyEstrogen Receptor (ER) alpha P2 and P3, ER gamma Polyclonal AbsES-079
 Rabbit Antibodies to Mouse and Human Lactoferrin and C3ES-081
 Mouse Monoclonal Antibody to Nitrone Spin Trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO)ES-086
 Monoclonal Antibody to Human DNA Polymerase BetaES-100
 Polyclonal Antibodies to Ser 134 Phosphorylated form of the Human Glucocorticoid ReceptorES-107
 Mouse Monoclonal Antibodies to Human Tristetraprolin (TTP)ES-112
 Monoclonal Antibodies Inhibitory to Human CYP2J2ES-116
 Polyclonal Antibodies to Human CYP2J and CYP2CES-117
 Antibody to pro-peptide of NSAID-activated Gene (NAG-1)/GDF-15ES-125
CellsChinese Hamster Ovary (CHO) Cells Expressing Retinoid Orphan Receptor (ROR)γ and Luciferase ReporterES-108
Methods & ReagentsTransformation Associated Recombination System in Yeast for Specific Cloning of DNAs as Yeast Artificial ChromosomesES-017
 Rapid, Efficient In Vivo site-Directed Mutagenesis Using OligonucleotidesES-054
 Mouse LactoferrinES-081
 An Efficient and Cost-Effective Assay for Genotyping Mice using Melting Curve AnalysisES-114
 Human CYP2J and CYP2CES-117
 Purified Human DNA Polymerase GES-120
 Fluorescent Intracellular Calcium IndicatorsES-124
Mouse ModelsEstrogen Receptor (ER)-alpha & ER-beta KO MiceES-002
 Mouse Model for Early Onset CataractES-066
 Mouse Expressing Enhanced Signaling for Bone Morphogenetic Protein (BMP): A Model for Human DiseaseES-102
 Knock-In mouse and Embryonic Stem Cells Expressing Leukemia Inhibitory Factor (LIF)ES-109
 Transgenic Mouse Expressing Human Nonsteroidal anti-inflammatory drug-activated Gene  (NAG-1)ES-110
 Retinoid Orphan Receptor (ROR)γ Deficient MiceES-113
 Mouse Strain with Conditional Deletion of SMAD7 geneES-115
 Transgenic Mouse with Cre recombinase Expressed in Spermatogenic cells under Regulation of the Hspa2 Gene PromoterES-118
 Heat-shock Protein  A2 (Hspa2) Knock-out Mouse for Study of Spermatogenesis and Male InfertilityES-119
 GLI-Similar 3 (GLIS3) KO Mice and Mice in which GLIS3 is KO in Selective TissuesES-121
TherapeuticsAntagonists of Hyaluronan Signaling for Treatment of Airway inflammation and HyperresponsivenessES-126
 Anti-inflammatory Actions of Cytochrome P450 Epoxygenase-Derived EicosanoidsES-039
 Diagnostics and Therapeutics for HydrocephalusES-064
 Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson’s and Alzheimer’s DiseaseES-078
 Target for Development of Diagnostics and Therapeutics for Abnormal HematopoiesisES-095
 Lrch4 - a Novel Regulator of InflammationES-122
 Functional Blockade of Inter-alpha-trypsin Inhibitor to Reduce Ariway Hyperreactivity in Environmental and Chronic Respiratory DiseasesES-123

* For description of these technologies please go to the KITS (Knowledge & Technology Sharing website). This website provides detailed information on NIEHS technologies and those of several other NIH Institutes.  Contact the NIEHS-OTT for any additional information.


Back to Top

Share This Page:

Page Options:

Request Translation Services